Alan Aderem, Ph.D.

Dr. Alan Aderem, ISB cofounder and Director, is an internationally recognized immunologist and cell biologist who plays a central role in defining the scientific direction of the Institute and is responsible for overseeing the integration of the wide variety of disciplines within the organization. Aderem also leads a scientific team investigating the roles of the immune system in health and disease.
Speaker Website

Lawrence Corey, M.D.

Dr. Corey is Senior Vice President of the Fred Hutchinson Cancer Research Center (Seattle, Washington) and Principal Investigator of the HIV Vaccine Trials Network. He is an internationally known expert on infectious diseases and in 2008 was selected to the Institute of Medicine of the National Academy of Sciences. His research is focused on the pathogenesis, prevention, and treatment of HIV and herpes virus infections, including the development of experimental vaccines against these viruses.
Speaker Website

Michael Katze, Ph.D.

Dr. Michael Katze is Professor of Microbiology and Associate Director and Core Staff Scientist at the Washington National Primate Research Center. Dr. Katze is recognized as a leader in applying genomic and proteomic technologies to the study of virus-host interactions and the interferon response. He heads a laboratory of over 30 individuals, including graduate students, postdoctoral fellows, research scientists, software engineers, and bioinformatics and information technology specialists.
Speaker Website

Rafick Sékaly, Ph.D.

Dr. Sékaly currently serves as Scientific Director of basic research and strategic planning and Director of the Laboratory of Microbiology and Immunology for the University of Montreal Hospital Research Center. He is regarded as one of the world’s leading immunologists, with extensive expertise in AIDS research, and has recently been named Director of the Vaccine and Gene Therapy Institute of Florida. Dr. Sékaly has also recently received considerable attention for his work combining targeted chemotherapy and highly active antiretroviral therapy (HAART) as an improved treatment for HIV/AIDS.
Speaker Website

Betsy Ferguson, Ph.D.

Ashley Haase, M.D.

Nathaniel Heintz, Ph.D.

Wang Jun, Ph.D.

Brandon Keele, Ph.D.

Elaine R. Mardis, Ph.D.

Gregory Miller, Ph.D.

Martha Neuringer, Ph.D.

David O'Connor, Ph.D.

Jeffrey Rogers, Ph.D.

Douglas Rosene, Ph.D.

Erika Sasaki, Ph.D.

Gary Schroth, Ph.D.

Jay Shendure, Ph.D.

Guido Silvestri, M.D.

David Glenn Smith, Ph.D.

Richard Weindruch, Ph.D.

Stuart Zola, Ph.D.